Hosted on MSN19d
Study reveals novel insights into the molecular pathology of esophageal squamous cell carcinomaEsophageal squamous cell carcinoma (ESCC) is a highly aggressive malignancy with poor prognosis, and understanding the molecular mechanisms underlying its progression is crucial for developing ...
The most common types of esophageal cancer are squamous cell carcinoma and adenocarcinoma ... Esophageal cancer can be diagnosed through an imaging test (CT or CAT, MRI or PET scans), a barium swallow ...
The addition of sintilimab to neoadjuvant chemoradiotherapy achieved a 60% pathological complete response rate vs 47.3% with chemoradiotherapy alone in locally advanced ESCC.
20d
Medpage Today on MSNNeoadjuvant Chemoradiation Plus Immunotherapy Boosts Responses in Esophageal CancerThe phase III ESCORT-NEO trial evaluated camrelizumab in combination with chemotherapy versus chemotherapy alone in the neoadjuvant setting and found that the former improved the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results